Please email the editors at 'theniche at nature.com' to propose new posts.

« Stopping snake-oil stem cell treatments | Main | CIRM's melting pot of collaborators, and its chair's potential half-million dollar salary »

Bookmark in Connotea

Europe says no to Thomson patent

Geron is unhappy that the European Patent Office has rejected claims of patents it has licensed from the Wisconsin Alumni Research Foundation. The argument as I understand it is that the European Patent Office followed rules forbidding patents on inventions that involve the destruction of embryos. Geron argued that nowadays researchers don’t have to destroy embryos because they can get embryonic stem cell lines from a cell bank, but the EPO didn’t buy that. (But you can read the arguments for yourself at the EPO.) For Geron’s side, see the press release . WARF’s press release emphasized that the decision was based on laws peculiar to Europe and had no bearing in the US.

Despite opposition from many scientists and activists, WARF’s claims over embryonic stem cells were upheld earlier this year. The first two in March, (See Nature news story) and the third in June.(See WARF press release.
(See also A perfect storm in patents )

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/6833

Post a comment

Comments will be reviewed by the blog editors before being published, mainly to ensure that spam and irrelevant material (such as product advertisements) are not published . Please keep your comment brief. Excessively long or offensively phrased entries will be edited.

We strongly encourage you to use your real, full name. E-mail addresses are required in case we need to discuss your comment with you directly. We won't publish your e-mail address unless you request it.

Please enter the numbers you see below - this helps us to avoid spam. If you are having trouble with this system, you can send your comment by e-mail to 'theniche at nature.com'.

please enter code